|
시장보고서
상품코드
2050637
임상 미생물학 시장 : 제품 유형별, 질환 유형별, 최종사용자별, 지역별Clinical Microbiology Market, By Product Type, By Disease Type, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
임상 미생물학 시장은 2026년에 55억 7,000만 달러로 추정되고 있으며, 2033년까지 82억 6,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 5.8%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 55억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 5.80% | 2033년 시장 규모 예측 : | 82억 6,000만 달러 |
전 세계 임상 미생물학 시장은 전 세계적인 감염병의 확산으로 인해 강력한 성장세를 보이고 있습니다. 감염에 취약한 고령 인구의 증가, 질병 진단에 대한 인식 증가, 분석 장비의 기술 발전 등의 요인이 시장 성장을 촉진하고 있습니다. 또한 정부 및 민간단체의 질병 진단에 대한 의식의 향상를 위한 다양한 노력도 시장 성장을 촉진할 수 있습니다.
시장 역학
세계의 임상 미생물학 시장의 성장은 전 세계 감염성 질환의 발생률 증가 등의 요인에 의해 주도되고 있습니다. 세계보건기구(WHO)에 따르면 감염성 질환은 매년 전 세계에서 약 1,700만 명의 사망 원인이 되고 있습니다. 질병의 조기 진단에 대한 인식이 높아지고, 첨단 진단 기술의 보급이 시장 성장을 촉진할 것으로 예상됩니다. 또한 각국 정부의 의료비 증가도 시장 성장을 촉진할 수 있습니다. 그러나 자동화 장비의 높은 비용이 시장 성장을 저해할 수 있습니다. 또한 후진국 및 개발도상국의 인프라 및 숙련된 전문가 부족도 시장 성장을 제한하는 요인으로 작용하고 있습니다. 첨단 미생물학 진단 솔루션을 개발하기 위한 지속적인 연구개발 활동은 시장 참여자들에게 유망한 기회를 제공하고 있습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 매출 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 글로벌 임상 미생물학 시장의 주요 기업 개요을 작성하기 위해 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략 등 다양한 매개 변수를 기반으로 합니다.
- 본 조사에서 다루어지고 있는 주요 기업에는 Danaher, Abbott, Hologic, Inc., Bruker, Bio-Rad Laboratories, Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Analytik Jena GmbH+Co. KG, Biolab Scientific, Reichert, Inc., BIOBASE GROUP, Cole-Parmer Instrument Company, LLC., ESICO INTERNATIONAL, Isolab Laborgerate GmbH, Eppendorf SE, Biosan, Beckman Coulter, Inc., NuAire, Inc. 등이 포함됩니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 세계의 임상 미생물학 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 임상 미생물학 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 임상 미생물학 시장 : 제품 유형별, 2026-2033년
제5장 세계의 임상 미생물학 시장 : 질환 유형별, 2026-2033년
제6장 세계의 임상 미생물학 시장 : 최종사용자별, 2026-2033년
제7장 세계의 임상 미생물학 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSA 26.06.10Clinical Microbiology Market is estimated to be valued at USD 5.57 Bn in 2026 and is expected to reach USD 8.26 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.57 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 8.26 Bn |
Global clinical microbiology market is witnessing strong growth due to increasing prevalence of infectious diseases worldwide. Factors such as rising geriatric population which is more prone to infectious diseases, growing awareness about disease diagnosis, and technological advancements in analytical instruments are driving the market growth. Moreover, various initiatives by government and private organizations to promote awareness about disease diagnosis can drive the market growth.
Market Dynamics
Global clinical microbiology market growth is driven by factors such as rising incidence of infectious diseases across the globe. According to the World Health Organization (WHO), infectious diseases account for approximately 17 million deaths globally every year. Growing awareness about timely diagnosis of diseases and availability of advanced diagnostic technologies are expected to drive the market growth. Moreover, increasing healthcare expenditure by governments of various countries can also drive the market growth. However, high cost of automated instruments can hamper the market growth. Lack of infrastructure and skilled professionals in underdeveloped and developing nations restrict the market growth. Ongoing research & development activities to develop advanced microbiology diagnostic solutions present lucrative opportunities for market players.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global clinical microbiology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this includes Danaher, Abbott, Hologic, Inc., Bruker, Bio-Rad Laboratories, Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Analytik Jena GmbH+Co. KG, Biolab Scientific, Reichert, Inc., BIOBASE GROUP, Cole-Parmer Instrument Company, LLC., ESICO INTERNATIONAL, Isolab Laborgerate GmbH, Eppendorf SE, Biosan, Beckman Coulter, Inc., NuAire, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global clinical microbiology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical microbiology market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Laboratory Instruments
- Incubators
- Gram Stainers
- Bacterial Colony Counters
- Autoclave Sterilizers
- Petri Dish Fillers
- Automated Culture Systems
- Microbiology Analyzers
- Microscopes
- Molecular Diagnostic Instruments
- Mass Spectrometers
- Reagents
- Disease Type Insights (Revenue, USD Bn, 2026 - 2033)
- Respiratory Diseases
- Bloodstream Infections
- Gastrointestinal Diseases
- Others
- End User Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals
- Custom Lab Service Providers
- Academic & Research Institutes
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Danaher
- Abbott
- Hologic, Inc.
- Bruker
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Analytik Jena GmbH+Co. KG
- Biolab Scientific
- Reichert, Inc.
- BIOBASE GROUP
- Cole-Parmer Instrument Company, LLC.
- ESICO INTERNATIONAL
- Isolab Laborgerate GmbH
- Eppendorf SE
- Biosan
- Beckman Coulter, Inc.
- NuAire, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Disease Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Clinical Microbiology Market, By Product Type, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Laboratory Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Incubators
- Gram Stainers
- Bacterial Colony Counters
- Autoclave Sterilizers
- Petri Dish Fillers
- Automated Culture Systems
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Microbiology Analyzers
- Microscopes
- Molecular Diagnostic Instruments
- Mass Spectrometers
- Reagents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
5. Global Clinical Microbiology Market, By Disease Type, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Bloodstream Infections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Gastrointestinal Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
6. Global Clinical Microbiology Market, By End User, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Custom Lab Service Providers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
7. Global Clinical Microbiology Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2026 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Danaher
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bruker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Analytik Jena GmbH+Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biolab Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reichert, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BIOBASE GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cole-Parmer Instrument Company, LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ESICO INTERNATIONAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Isolab Laborgerate GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eppendorf SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biosan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NuAire, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
